Evidence map›Paper›PMID 30996049›Full record

ArticleCancer research2019

tRNA Fragments Show Intertwining with mRNAs of Specific Repeat Content and Have Links to Disparities.

Aristeidis G Telonis, Phillipe Loher, Rogan Magee, Venetia Pliatsika, Eric Londin, Yohei Kirino, Isidore Rigoutsos

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Emerging roles of transfer RNA fragments in the CNS.Brain : a journal of neurology · 2025
    Review
  12. Article
  13. The Roles of tRNA-Derived Fragments in Cancer: Updates and Perspectives.International journal of molecular sciences · 2025
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Aristeidis G TelonisComputational Medicine Center, Thomas Jefferson University, Philadelphia, Pennsylvania.ORCID 0000-0003-1575-2769
Phillipe LoherComputational Medicine Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Rogan MageeComputational Medicine Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Venetia PliatsikaComputational Medicine Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Eric LondinComputational Medicine Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Yohei KirinoComputational Medicine Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Isidore RigoutsosComputational Medicine Center, Thomas Jefferson University, Philadelphia, Pennsylvania. isidore.rigoutsos@jefferson.edu.ORCID 0000-0003-1529-8631
Thomas Jefferson University · US

Funding

Discovery of Novel miRNAs and isomiRs and Use in Sub-typing TCGA CancersR21CA195204 · NCI · THOMAS JEFFERSON UNIVERSITY · PI RIGOUTSOS, ISIDORE · 2016 to 2017
$373k
NCI NIH HHS R21 CA195204
6 · The paper itself

Abstract

tRNA-derived fragments (tRF) are a class of potent regulatory RNAs. We mined the datasets from The Cancer Genome Atlas (TCGA) representing 32 cancer types with a deterministic and exhaustive pipeline for tRNA fragments. We found that mitochondrial tRNAs contribute disproportionally more tRFs than nuclear tRNAs. Through integrative analyses, we uncovered a multitude of statistically significant and context-dependent associations between the identified tRFs and mRNAs. In many of the 32 cancer types, these associations involve mRNAs from developmental processes, receptor tyrosine kinase signaling, the proteasome, and metabolic pathways that include glycolysis, oxidative phosphorylation, and ATP synthesis. Even though the pathways are common to multiple cancers, the association of specific mRNAs with tRFs depends on and differs from cancer to cancer. The associations between tRFs and mRNAs extend to genomic properties as well; specifically, tRFs are positively correlated with shorter genes that have a higher density in repeats, such as ALUs, MIRs, and ERVLs. Conversely, tRFs are negatively correlated with longer genes that have a lower repeat density, suggesting a possible dichotomy between cell proliferation and differentiation. Analyses of bladder, lung, and kidney cancer data indicate that the tRF-mRNA wiring can also depend on a patient's sex. Sex-dependent associations involve cyclin-dependent kinases in bladder cancer, the MAPK signaling pathway in lung cancer, and purine metabolism in kidney cancer. Taken together, these findings suggest diverse and wide-ranging roles for tRFs and highlight the extensive interconnections of tRFs with key cellular processes and human genomic architecture. SIGNIFICANCE: Across 32 TCGA cancer contexts, nuclear and mitochondrial tRNA fragments exhibit associations with mRNAs that belong to concrete pathways, encode proteins with particular destinations, have a biased repeat content, and are sex dependent.

Indexed as

Gene Regulatory NetworksGenome, HumanHealth Status DisparitiesCell NucleusCell ProliferationHumansMitochondriaNeoplasmsRNA, MessengerRNA, TransferTranscriptomeRNA, MessengerRNA, Transfer

Identifiers

PMID30996049
PMCPMC6571059
OpenAlexW2937316677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.